How much profit has Darya-Varia Laboratoria Tbk PT made this year?
Darya-Varia Laboratoria Tbk PT has made 146.34 B IDR this year.
In 2024, Darya-Varia Laboratoria Tbk PT's profit amounted to 146.34 B IDR, a -2.03% increase from the 149.38 B IDR profit recorded in the previous year.
YEAR | NET INCOME (undefined IDR) |
---|---|
2023 | 146.34 |
2022 | 149.38 |
2021 | 146.51 |
2020 | 162.07 |
2019 | 221.78 |
2018 | 200.65 |
2017 | 162.25 |
2016 | 152.08 |
2015 | 107.89 |
2014 | 81.6 |
2013 | 125.8 |
2012 | 148.91 |
2011 | 120.92 |
2010 | 110.88 |
2009 | 72.27 |
2008 | 70.82 |
2007 | 49.92 |
2006 | 52.51 |
2005 | 71.58 |
2004 | 49.81 |
3 years
5 years
10 years
Max
Gain insights into Darya-Varia Laboratoria Tbk PT, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Darya-Varia Laboratoria Tbk PT from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Darya-Varia Laboratoria Tbk PT’s net earnings, an ultimate measure of its financial health and profitability.
Observe the yearly bars to understand the annual performance and growth of Darya-Varia Laboratoria Tbk PT. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
The expected values for the forthcoming years offer investors a glimpse into Darya-Varia Laboratoria Tbk PT’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Leveraging the comparison between Revenue and EBIT helps in assessing Darya-Varia Laboratoria Tbk PT’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Darya-Varia Laboratoria Tbk PT’s growth potential.
Date | Darya-Varia Laboratoria Tbk PT Revenue | Darya-Varia Laboratoria Tbk PT EBIT | Darya-Varia Laboratoria Tbk PT Net Income |
---|---|---|---|
2023 | 1.89 T IDR | 192.31 B IDR | 146.34 B IDR |
2022 | 1.92 T IDR | 193.3 B IDR | 149.38 B IDR |
2021 | 1.9 T IDR | 198.86 B IDR | 146.51 B IDR |
2020 | 1.83 T IDR | 209.36 B IDR | 162.07 B IDR |
2019 | 1.81 T IDR | 305.25 B IDR | 221.78 B IDR |
2018 | 1.7 T IDR | 259.98 B IDR | 200.65 B IDR |
2017 | 1.58 T IDR | 220 B IDR | 162.25 B IDR |
2016 | 1.45 T IDR | 205.05 B IDR | 152.08 B IDR |
2015 | 1.31 T IDR | 121.82 B IDR | 107.89 B IDR |
2014 | 1.1 T IDR | 100.71 B IDR | 81.6 B IDR |
2013 | 1.1 T IDR | 155.12 B IDR | 125.8 B IDR |
2012 | 1.09 T IDR | 189.23 B IDR | 148.91 B IDR |
2011 | 972.3 B IDR | 143.03 B IDR | 120.92 B IDR |
2010 | 929.2 B IDR | 134.63 B IDR | 110.88 B IDR |
2009 | 869.17 B IDR | 116.87 B IDR | 72.27 B IDR |
2008 | 577.6 B IDR | 75.71 B IDR | 70.82 B IDR |
2007 | 509.5 B IDR | 65.2 B IDR | 49.92 B IDR |
2006 | 576.67 B IDR | 76.07 B IDR | 52.51 B IDR |
2005 | 540.44 B IDR | 73.8 B IDR | 71.58 B IDR |
2004 | 426.8 B IDR | 77.61 B IDR | 49.81 B IDR |
Revenue | EBIT | Net Income | |
---|---|---|---|
2004 | 426.8 B IDR | 77.61 B IDR | 49.81 B IDR |
2005 | 540.44 B IDR | 73.8 B IDR | 71.58 B IDR |
2006 | 576.67 B IDR | 76.07 B IDR | 52.51 B IDR |
2007 | 509.5 B IDR | 65.2 B IDR | 49.92 B IDR |
2008 | 577.6 B IDR | 75.71 B IDR | 70.82 B IDR |
2009 | 869.17 B IDR | 116.87 B IDR | 72.27 B IDR |
2010 | 929.2 B IDR | 134.63 B IDR | 110.88 B IDR |
2011 | 972.3 B IDR | 143.03 B IDR | 120.92 B IDR |
2012 | 1.09 T IDR | 189.23 B IDR | 148.91 B IDR |
2013 | 1.1 T IDR | 155.12 B IDR | 125.8 B IDR |
2014 | 1.1 T IDR | 100.71 B IDR | 81.6 B IDR |
2015 | 1.31 T IDR | 121.82 B IDR | 107.89 B IDR |
2016 | 1.45 T IDR | 205.05 B IDR | 152.08 B IDR |
2017 | 1.58 T IDR | 220 B IDR | 162.25 B IDR |
2018 | 1.7 T IDR | 259.98 B IDR | 200.65 B IDR |
2019 | 1.81 T IDR | 305.25 B IDR | 221.78 B IDR |
2020 | 1.83 T IDR | 209.36 B IDR | 162.07 B IDR |
2021 | 1.9 T IDR | 198.86 B IDR | 146.51 B IDR |
2022 | 1.92 T IDR | 193.3 B IDR | 149.38 B IDR |
2023 | 1.89 T IDR | 192.31 B IDR | 146.34 B IDR |
3 years
5 years
10 years
Max
The gross margin, expressed as a percentage, delineates the gross profit made from the Darya-Varia Laboratoria Tbk PT's sales revenue. A higher gross margin percentage indicates that the Darya-Varia Laboratoria Tbk PT retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT margin represents the Darya-Varia Laboratoria Tbk PT's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
The revenue margin demonstrates the Darya-Varia Laboratoria Tbk PT's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Darya-Varia Laboratoria Tbk PT's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Darya-Varia Laboratoria Tbk PT. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Darya-Varia Laboratoria Tbk PT's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Darya-Varia Laboratoria Tbk PT Gross margin | Darya-Varia Laboratoria Tbk PT Profit margin | Darya-Varia Laboratoria Tbk PT EBIT margin | Darya-Varia Laboratoria Tbk PT Profit margin |
---|---|---|---|
2023 | 51.58 % | 10.17 % | 7.74 % |
2022 | 52.48 % | 10.08 % | 7.79 % |
2021 | 52.38 % | 10.46 % | 7.71 % |
2020 | 50.94 % | 11.44 % | 8.86 % |
2019 | 53.69 % | 16.84 % | 12.23 % |
2018 | 54.45 % | 15.3 % | 11.81 % |
2017 | 56.74 % | 13.96 % | 10.3 % |
2016 | 55.22 % | 14.13 % | 10.48 % |
2015 | 51.89 % | 9.33 % | 8.26 % |
2014 | 53.05 % | 9.12 % | 7.39 % |
2013 | 59.97 % | 14.08 % | 11.42 % |
2012 | 59.88 % | 17.4 % | 13.69 % |
2011 | 64.1 % | 14.71 % | 12.44 % |
2010 | 63.24 % | 14.49 % | 11.93 % |
2009 | 61.68 % | 13.45 % | 8.32 % |
2008 | 64.69 % | 13.11 % | 12.26 % |
2007 | 63.84 % | 12.8 % | 9.8 % |
2006 | 65.98 % | 13.19 % | 9.11 % |
2005 | 65.79 % | 13.66 % | 13.24 % |
2004 | 66.4 % | 18.18 % | 11.67 % |
Gross margin | EBIT margin | Profit margin | |
---|---|---|---|
2004 | 66.4 % | 18.18 % | 11.67 % |
2005 | 65.79 % | 13.66 % | 13.24 % |
2006 | 65.98 % | 13.19 % | 9.11 % |
2007 | 63.84 % | 12.8 % | 9.8 % |
2008 | 64.69 % | 13.11 % | 12.26 % |
2009 | 61.68 % | 13.45 % | 8.32 % |
2010 | 63.24 % | 14.49 % | 11.93 % |
2011 | 64.1 % | 14.71 % | 12.44 % |
2012 | 59.88 % | 17.4 % | 13.69 % |
2013 | 59.97 % | 14.08 % | 11.42 % |
2014 | 53.05 % | 9.12 % | 7.39 % |
2015 | 51.89 % | 9.33 % | 8.26 % |
2016 | 55.22 % | 14.13 % | 10.48 % |
2017 | 56.74 % | 13.96 % | 10.3 % |
2018 | 54.45 % | 15.3 % | 11.81 % |
2019 | 53.69 % | 16.84 % | 12.23 % |
2020 | 50.94 % | 11.44 % | 8.86 % |
2021 | 52.38 % | 10.46 % | 7.71 % |
2022 | 52.48 % | 10.08 % | 7.79 % |
2023 | 51.58 % | 10.17 % | 7.74 % |
The profit margins of Darya-Varia Laboratoria Tbk PT represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Darya-Varia Laboratoria Tbk PT's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.
Evaluating Darya-Varia Laboratoria Tbk PT's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.
Darya-Varia Laboratoria Tbk PT's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.
When Darya-Varia Laboratoria Tbk PT’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.
Darya-Varia Laboratoria Tbk PT has made 146.34 B IDR this year.
The profit has increased by -2.03% compared to last year fallen
An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.
Darya-Varia Laboratoria Tbk PT publishes its earnings in the form of quarterly or annual reports.
The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.
The profits of Darya-Varia Laboratoria Tbk PT are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.
You can learn more about the earnings of Darya-Varia Laboratoria Tbk PT by reviewing the quarterly or annual reports or following the company presentations.
Over the past 12 months, Darya-Varia Laboratoria Tbk PT paid a dividend of 121 IDR . This corresponds to a dividend yield of about 7.78 %. For the coming 12 months, Darya-Varia Laboratoria Tbk PT is expected to pay a dividend of 121 IDR.
The current dividend yield of Darya-Varia Laboratoria Tbk PT is 7.78 %.
Darya-Varia Laboratoria Tbk PT pays a quarterly dividend. This is distributed in the months of August, December, August, December.
Darya-Varia Laboratoria Tbk PT paid dividends every year for the past 16 years.
For the upcoming 12 months, dividends amounting to 121 IDR are expected. This corresponds to a dividend yield of 7.78 %.
Darya-Varia Laboratoria Tbk PT is assigned to the 'Health' sector.
To receive the latest dividend of Darya-Varia Laboratoria Tbk PT from 11/28/2023 amounting to 43 IDR, you needed to have the stock in your portfolio before the ex-date on 11/13/2023.
The last dividend was paid out on 11/28/2023.
In the year 2023, Darya-Varia Laboratoria Tbk PT distributed 116 IDR as dividends.
The dividends of Darya-Varia Laboratoria Tbk PT are distributed in IDR.
Our stock analysis for Darya-Varia Laboratoria Tbk PT Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Darya-Varia Laboratoria Tbk PT Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.